Preoperative transferrin level is a novel prognostic marker for colorectal cancer.

AIM

This study investigated whether preoperative serum transferrin, a rapid-turnover protein, was associated with prognosis after colorectal cancer (CRC) resection.

METHODS

We evaluated preoperative transferrin, which was calculated as iron and unsaturated iron-binding capacity, in 501 patients who underwent surgery for Stage I-III CRC. Transferrin level was directly proportional to total iron-binding capacity (TIBC), and TIBC < 250 μg/dl was defined as low transferrin. The associations between transferrin and prognosis were evaluated in univariate and multivariate Cox proportional hazards analyses.

RESULTS

Fifty-eight of 501 patients (11.5%) had low transferrin. In these patients, low transferrin was significantly associated with high age, female gender, low body mass index (<18.5), high white blood cell count, low total protein, low albumin, high C-reactive protein, low hemoglobin, and low neutrophil/lymphocyte ratio. In the univariate analysis, low transferrin was associated with shorter relapse-free survival (RFS) (hazard ratio [HR] 2.180, 95% confidence interval [CI] 1.417-3.354,  < .001), overall survival (OS) (HR 2.930, 95% CI 1.784-4.811,  < .001), and cancer-specific survival (CSS) (HR 2.122, 95% CI 1.053-4.275,  = .035). In multivariate analysis, high age ( < .001), Glasgow Prognostic Score ( = .009), and low transferrin (HR 2.336, 95% CI 1.173-4.654,  = .011) were independently associated with shorter OS, and depth of invasion pT4 ( = .015), presence of lymph node metastasis ( = .001), low hemoglobin ( = .034), and low transferrin (HR 2.638, 95% CI 1.113-5.043,  = .025) were independently associated with shorter CSS.

CONCLUSIONS

Preoperative serum transferrin in Stage I-III CRC patients was identified as a novel prognostic marker by univariate and multivariate analyses.